Jacklynn M Fitzgerald1, Annmarie MacNamara2, Amy E Kennedy2,3, Christine A Rabinak4, Sheila A M Rauch5, Israel Liberzon6, K Luan Phan1,2,3. 1. Department of Psychology, University of Illinois at Chicago, Chicago, IL, USA. 2. Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA. 3. Jesse Brown VA Medical Center, Chicago, IL, USA. 4. Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA. 5. Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta VA Medical Center, Atlanta, GA, USA. 6. Department of Psychiatry, University of Michigan, Ann Arbor VA Healthcare System, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Veterans with posttraumatic stress disorder (PTSD) exhibit marked deficits in emotion regulation. Past research has demonstrated underengagement of the prefrontal cortex during regulation of negative affect in those with PTSD, but has been unable to find evidence of impaired downregulation of the amygdala. One possibility is that there exists variability in amygdala reactivity that cuts across diagnostic status and which can be characterized using a continuous measure of individual differences. In healthy/nontraumatized volunteers, individual variability in amygdala engagement during emotion processing and regulation has been shown to relate to habitual use of regulation strategies. METHODS: The current study examined whether self-reported use of cognitive reappraisal and expressive suppression regulation strategies correlated with brain activation during cognitive reappraisal in combat-exposed veterans with (n = 28) and without PTSD (combat-exposed controls, CEC; n = 20). RESULTS: Results showed that greater self-reported use of cognitive reappraisal was associated with less activation in the right amygdala during volitional attempts to attenuate negative affect using reappraisal, irrespective of PTSD diagnosis. CONCLUSIONS: This finding is in line with prior work and extends evidence of an association between habitual use of regulation strategies and amygdala engagement during emotion regulation to a trauma-exposed sample of individuals both with and without PTSD. Furthermore, by providing evidence of individual differences in regulation-related amygdala response in a traumatized sample, this result may increase understanding of the neural mechanisms that support variability in symptom manifestation observed across individuals with PTSD.
BACKGROUND: Veterans with posttraumatic stress disorder (PTSD) exhibit marked deficits in emotion regulation. Past research has demonstrated underengagement of the prefrontal cortex during regulation of negative affect in those with PTSD, but has been unable to find evidence of impaired downregulation of the amygdala. One possibility is that there exists variability in amygdala reactivity that cuts across diagnostic status and which can be characterized using a continuous measure of individual differences. In healthy/nontraumatized volunteers, individual variability in amygdala engagement during emotion processing and regulation has been shown to relate to habitual use of regulation strategies. METHODS: The current study examined whether self-reported use of cognitive reappraisal and expressive suppression regulation strategies correlated with brain activation during cognitive reappraisal in combat-exposed veterans with (n = 28) and without PTSD (combat-exposed controls, CEC; n = 20). RESULTS: Results showed that greater self-reported use of cognitive reappraisal was associated with less activation in the right amygdala during volitional attempts to attenuate negative affect using reappraisal, irrespective of PTSD diagnosis. CONCLUSIONS: This finding is in line with prior work and extends evidence of an association between habitual use of regulation strategies and amygdala engagement during emotion regulation to a trauma-exposed sample of individuals both with and without PTSD. Furthermore, by providing evidence of individual differences in regulation-related amygdala response in a traumatized sample, this result may increase understanding of the neural mechanisms that support variability in symptom manifestation observed across individuals with PTSD.
Authors: Marie-Anne Vanderhasselt; Chris Baeken; Peter Van Schuerbeek; Rob Luypaert; Rudi De Raedt Journal: Biol Psychol Date: 2012-03-16 Impact factor: 3.251
Authors: Andrew H Kemp; Kim L Felmingham; Erin Falconer; Belinda J Liddell; Richard A Bryant; Leanne M Williams Journal: Psychiatry Res Date: 2009-11-30 Impact factor: 3.222
Authors: Brady D Nelson; Daniel A Fitzgerald; Heide Klumpp; Stewart A Shankman; K Luan Phan Journal: Behav Brain Res Date: 2014-11-26 Impact factor: 3.332
Authors: Kristen M Wrocklage; Lynnette A Averill; J Cobb Scott; Christopher L Averill; Brian Schweinsburg; Marcia Trejo; Alicia Roy; Valerie Weisser; Christopher Kelly; Brenda Martini; Ilan Harpaz-Rotem; Steven M Southwick; John H Krystal; Chadi G Abdallah Journal: Eur Neuropsychopharmacol Date: 2017-03-06 Impact factor: 4.600
Authors: Simon B Goldberg; Anthony W P Flynn; Maleeha Abbas; Megan E Schultz; Michele Hiserodt; Kathryn A Thomas; Kasey Kallio; Mary F Wyman Journal: Couns Psychol Date: 2022-01-27
Authors: Sonalee A Joshi; Elizabeth R Duval; Jony Sheynin; Anthony P King; K Luan Phan; Brian Martis; Katherine E Porter; Israel Liberzon; Sheila A M Rauch Journal: Psychiatry Res Neuroimaging Date: 2020-03-05 Impact factor: 2.493
Authors: Heide Klumpp; Jacklynn M Fitzgerald; Kerry L Kinney; Amy E Kennedy; Stewart A Shankman; Scott A Langenecker; K Luan Phan Journal: Neuroimage Clin Date: 2017-04-12 Impact factor: 4.881
Authors: Katerina Stephanou; Christopher G Davey; Rebecca Kerestes; Sarah Whittle; Ben J Harrison Journal: Soc Cogn Affect Neurosci Date: 2017-07-01 Impact factor: 3.436